Despite a research focus completely unrelated to COVID-19, Camarillo’s ImmPACT Bio managed to accomplish something unusual: It garnered $18 million when its Series A funding round closed in August...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 26 biweekly issues
  • Subscriber-only digital content for prime stories
  • Book of Lists — the most comprehensive business resource in the Valley region
Yours for only $49